LevitasBio, founded with the mission to revolutionize cell separation technology, offers innovative solutions that enable label-free sorting of cells. Their core product, LeviCell, provides a fast, reliable, and gentle method for cell separation without the need for markers or modifications. This technology is crucial for applications in single-cell genomics, viable cell enrichment, and flow cytometry. LevitasBio primarily targets researchers and professionals in the biomedical and life sciences sectors.
Notable figures affiliated with LevitasBio include experts in biotechnology and cell biology, although specific names are not provided. The company has garnered attention from investors interested in cutting-edge life sciences technologies. Key achievements include the successful launch and adoption of LeviCell, which has been recognized for its efficiency and minimal impact on cell viability. LevitasBio's impact is significant in advancing research capabilities and improving outcomes in various scientific fields.
